FIELD: medicine.
SUBSTANCE: group of inventions relates to methods of treating or preventing disorders of the liver, bile ducts and pancreas. A method of treating or preventing a liver disease or disorder selected from a group consisting of toxic liver damage, alcoholic or non-alcoholic fatty liver disease (NAFLD), hepatic cirrhosis, hepatic insufficiency, hepatic fibrosis, liver sclerosis, hepatic encephalopathy, non-alcoholic steatohepatitis (NASH), wherein said method comprises administering an effective amount of α-defensin and/or β-defensin of mammals selected from a group consisting of hBD-2 (SEQ ID NO: 5), truncated hBD2 (SEQ ID NO: 17), hBD-1 (SEQ ID NO: 4), hBD-3 (SEQ ID NO: 6), and hBD-4 (SEQ ID NO: 7), β-defensin, which differs from hBD1, hBD2, hBD3, hBD4, or truncated hBD2 (SEQ ID NO: 17) by less than 5 conserved amino acid substitutions, HD5 (SEQ ID NO: 8), and/or HD6 (SEQ ID NO: 9), a subject in need thereof. Also disclosed are a method of treating or preventing a biliary disease or disorder, a method of treating or preventing a disease or a pancreatic disorder, method of treating or preventing a metabolic disease or disorder, using α-defensin and/or β-defensin in mammals in a method of treating and preparing a medicinal agent.
EFFECT: treatment of liver, bile duct and pancreatic disorders is offered.
35 cl, 38 dwg, 10 ex
Title | Year | Author | Number |
---|---|---|---|
METHODS FOR MODULATING INTESTINAL MICROBIOTA | 2017 |
|
RU2738265C2 |
COMPOSITIONS AND METHODS FOR CONTROLLING ACCUMULATION OF ADIPOSE TISSUE | 2014 |
|
RU2711478C2 |
COMPOSITION FOR PREVENTING, IMPROVING OR TREATING OBESITY OR FATTY LIVER DISEASE CONTAINING LEUCONOSTOC CITREUM WiKim0104 | 2020 |
|
RU2816754C2 |
USE OF COMPOSITIONS CONTAINING BIFIDOBACTERIUM ANIMALIS SSP. LACTIS LMG P-28149 | 2015 |
|
RU2673341C2 |
FGF21 Fc FUNCTION PROTEIN, GLP-1 Fc FUNCTION PROTEIN AND COMBINED THERAPEUTIC AGENT INCLUDING THEM AND THEIR USE | 2020 |
|
RU2804335C2 |
STRAIN OF AKKERMANSIA MUCINIPHILA AND APPLICATION THEREOF | 2019 |
|
RU2777068C1 |
COMPOSITION FOR HYPERLIPIDEMIA TREATMENT CONTAINING OXYNTOMODULIN DERIVATIVE | 2013 |
|
RU2642267C2 |
AKKERMANSIA MUCINIPHILA STRAIN AND ITS APPLICATION | 2019 |
|
RU2792651C2 |
TREATMENT OF ABNORMAL VISCERAL FAT DEPOSITION WITH FIBROBLAST GROWTH FACTOR 3 (sFGFR3) SOLUBLE POLYPEPTIDES | 2018 |
|
RU2794170C2 |
PHARMACEUTICAL COMPOSITION INCLUDING A POLYPEPTIDE | 2019 |
|
RU2777095C1 |
Authors
Dates
2021-01-21—Published
2017-04-28—Filed